Your browser version may not work well with NCBI's Web applications. More information here...
1: Front Biosci. 2004 Sep 1;9:3085-90.Click here to read Links

Soluble interleukin-2 receptor in cancer.

Murakami S.

Department of Surgery, Saitama Medical School, Morohongo 38, Moyorama-machi, Iruma-gunn,Saitama, 350-0495, Japan. smurakam@saitama-med.ac.jp

Levels of serum sIL-2R (soluble interleukin-2 receptor) reflect the total amount of activated T lymphocytes in tumor infiltrating lymphocytes of cancer tissues and metastatic organs, because a part of alpha-chain of IL-2R is released into the bloodstream on the attachment of IL-2 (interleukin-2) to its specific IL-2R membrane. In most malignant diseases, elevated levels of serum sIL-2R are found, compare to normal control. Serum sIL-2R is a useful parameter for evaluating the disease stage and monitoring the disease progression during the post-treatment follow-up, though it is not an organ-specific parameter.

PMID: 15353339 [PubMed - indexed for MEDLINE]